Section Arrow
Quote
EVAX.NASDAQ
- Evaxion Biotech A/S
(Financial Status)
Quotes are at least 15-min delayed:2025/04/12 04:14 EDT
Last
 1.35
0 (0.00%)
Day High 
1.3794 
Prev. Close
1.35 
1-M High
1.9887 
Volume 
59.22K 
Bid
1.28
Ask
1.38
Day Low
1.32 
Open
1.34 
1-M Low
1.2 
Market Cap 
8.53M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.57 
20-SMA 1.7 
50-SMA 2.08 
52-W High 22.0475 
52-W Low 1.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-10.00/0.34
Enterprise Value
18.16M
Balance Sheet
Book Value Per Share
-0.26
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.34M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals5.76+1.25+27.72%-- 
THTXTheratechnologies1.94+0.61+45.86%-- 
CDTConduit Pharmaceuticals Inc0.9101-0.1599-14.94%-- 
PRTGPortage Biotech Inc8.59+3.49+68.43%0.17PE
HEPAHepion Pharmaceuticals0.422-0.0091-2.11%-- 
Quotes are at least 15-min delayed：2025/04/12 04:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are: EVX-01, EVX-03, and EVX-02, which are vaccine candidates being developed for the treatment of various solid cancers. In addition, the company is developing EVX-B1, EVX-B2, EVX-B3, EVX-V1, and multiple other vaccine candidates for various infectious diseases, such as cytomegalovirus, N.gonorrhoeae, bacterial pathogens, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.